image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC9415372_polymers-14-03258-f007_386105.jpg | What is the core subject represented in this visual? | Instrument of vacuum water saturation. |
PMC9415373_polymers-14-03375-f001_386114.jpg | What is the dominant medical problem in this image? | SEM images of the compounded PGAX blends (a–f) with magnification in (g,i) and the pristine PGA (h). |
PMC9415373_polymers-14-03375-f001_386107.jpg | What is the main focus of this visual representation? | SEM images of the compounded PGAX blends (a–f) with magnification in (g,i) and the pristine PGA (h). |
PMC9415373_polymers-14-03375-f001_386108.jpg | Can you identify the primary element in this image? | SEM images of the compounded PGAX blends (a–f) with magnification in (g,i) and the pristine PGA (h). |
PMC9415373_polymers-14-03375-f001_386109.jpg | Can you identify the primary element in this image? | SEM images of the compounded PGAX blends (a–f) with magnification in (g,i) and the pristine PGA (h). |
PMC9415373_polymers-14-03375-f001_386113.jpg | What does this image primarily show? | SEM images of the compounded PGAX blends (a–f) with magnification in (g,i) and the pristine PGA (h). |
PMC9415373_polymers-14-03375-f001_386106.jpg | What is the central feature of this picture? | SEM images of the compounded PGAX blends (a–f) with magnification in (g,i) and the pristine PGA (h). |
PMC9415373_polymers-14-03375-f001_386112.jpg | What can you see in this picture? | SEM images of the compounded PGAX blends (a–f) with magnification in (g,i) and the pristine PGA (h). |
PMC9415373_polymers-14-03375-f001_386111.jpg | What stands out most in this visual? | SEM images of the compounded PGAX blends (a–f) with magnification in (g,i) and the pristine PGA (h). |
PMC9415386_membranes-12-00781-f001_386140.jpg | What's the most prominent thing you notice in this picture? | Phase separation observed by fluorescence microscopy for DOPC/DPPC/MUFA/Chol: (a,e) 40/40/0/20, (b,f) 30/40/10/20 (MUFA = PaA), (c,g) 30/40/10/20 (MUFA = OA), and (d,h) 30/40/10/20 (MUFA = EiA). The upper (a–d) and lower (e–h) rows are the images at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress), resp... |
PMC9415386_membranes-12-00781-f001_386137.jpg | What does this image primarily show? | Phase separation observed by fluorescence microscopy for DOPC/DPPC/MUFA/Chol: (a,e) 40/40/0/20, (b,f) 30/40/10/20 (MUFA = PaA), (c,g) 30/40/10/20 (MUFA = OA), and (d,h) 30/40/10/20 (MUFA = EiA). The upper (a–d) and lower (e–h) rows are the images at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress), resp... |
PMC9415386_membranes-12-00781-f001_386141.jpg | What is the central feature of this picture? | Phase separation observed by fluorescence microscopy for DOPC/DPPC/MUFA/Chol: (a,e) 40/40/0/20, (b,f) 30/40/10/20 (MUFA = PaA), (c,g) 30/40/10/20 (MUFA = OA), and (d,h) 30/40/10/20 (MUFA = EiA). The upper (a–d) and lower (e–h) rows are the images at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress), resp... |
PMC9415386_membranes-12-00781-f001_386139.jpg | What key item or scene is captured in this photo? | Phase separation observed by fluorescence microscopy for DOPC/DPPC/MUFA/Chol: (a,e) 40/40/0/20, (b,f) 30/40/10/20 (MUFA = PaA), (c,g) 30/40/10/20 (MUFA = OA), and (d,h) 30/40/10/20 (MUFA = EiA). The upper (a–d) and lower (e–h) rows are the images at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress), resp... |
PMC9415386_membranes-12-00781-f003_386117.jpg | What stands out most in this visual? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386119.jpg | What is the central feature of this picture? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386129.jpg | What is shown in this image? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386126.jpg | What key item or scene is captured in this photo? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386125.jpg | Describe the main subject of this image. | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386121.jpg | What is the main focus of this visual representation? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386120.jpg | What is the central feature of this picture? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386132.jpg | What is the focal point of this photograph? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386127.jpg | What is shown in this image? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386135.jpg | What is the core subject represented in this visual? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386134.jpg | What is the focal point of this photograph? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386118.jpg | What is the central feature of this picture? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386128.jpg | What does this image primarily show? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386131.jpg | What is being portrayed in this visual content? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415386_membranes-12-00781-f003_386130.jpg | What object or scene is depicted here? | Phase-separated vesicles observed by confocal laser scanning microscopy for (a) DOPC/DPPC/MUFA/Chol = 40/40/0/20, (b) 30/40/10/20 (MUFA = PaA), (c) 30/40/10/20 (MUFA = OA), and (d) 30/40/10/20 (MUFA = EiA) at ΔC = 0 (without osmotic stress) and 180 mM (with osmotic stress). The red and green colors correspond to Rho-DH... |
PMC9415407_nanomaterials-12-02796-f002_386144.jpg | Describe the main subject of this image. | TEM images of Cobalt oxide nanowires at different magnifications, (a) low, and (b) high. |
PMC9415419_pharmaceutics-14-01713-f006_386155.jpg | What does this image primarily show? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386163.jpg | What is being portrayed in this visual content? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386167.jpg | What is the main focus of this visual representation? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386166.jpg | What object or scene is depicted here? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386161.jpg | What is shown in this image? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386151.jpg | What is shown in this image? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386164.jpg | Describe the main subject of this image. | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386146.jpg | Can you identify the primary element in this image? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386153.jpg | What is the principal component of this image? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386162.jpg | What is the focal point of this photograph? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386147.jpg | What is the central feature of this picture? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386148.jpg | What does this image primarily show? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386159.jpg | What is the principal component of this image? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386154.jpg | What is shown in this image? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386149.jpg | What is the central feature of this picture? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386152.jpg | What is the core subject represented in this visual? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386158.jpg | Describe the main subject of this image. | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386160.jpg | What is the core subject represented in this visual? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415419_pharmaceutics-14-01713-f006_386157.jpg | Can you identify the primary element in this image? | Morphology of kefiran scaffolds obtained from each extract, S1 (A,D), S2 (B,E), and S3 (C,F). (A–C) show the macroscopic image (i) of each scaffold (scale bar: 1 mm) and the SEM microstructures for longitudinal sections at magnifications of ×50 (ii) and ×150 (iii) and for cross-sectional (iv) and uncut (iii) views at ×... |
PMC9415430_medicina-58-01063-f001_386173.jpg | Can you identify the primary element in this image? | Pre-operative images. (a) Axial view of C spine CT showed a fracture in posterior element of C5-C6. (b) Sagittal view of C spine CT demonstrated traumatic spondylolisthesis of C6 on C7. (c) MRI T2-weighted image of C spine showed anterior subluxation of C6-7 with posterior HIVD, compressing the spinal cord, and soft ti... |
PMC9415430_medicina-58-01063-f001_386175.jpg | What is being portrayed in this visual content? | Pre-operative images. (a) Axial view of C spine CT showed a fracture in posterior element of C5-C6. (b) Sagittal view of C spine CT demonstrated traumatic spondylolisthesis of C6 on C7. (c) MRI T2-weighted image of C spine showed anterior subluxation of C6-7 with posterior HIVD, compressing the spinal cord, and soft ti... |
PMC9415430_medicina-58-01063-f003_386170.jpg | What is the core subject represented in this visual? | Postoperative Imaging. (a) MRI T2-weighted image of L spine showed L1 compression fracture, degenerative scoliosis without significant spinal stenosis or nerve root compression. (b) MRI T2-weighted image of cervical spine showed no new onset of intraspinal pathology. (c) Brain CT revealed no intracerebral hemorrhage, a... |
PMC9415430_medicina-58-01063-f003_386168.jpg | What is the main focus of this visual representation? | Postoperative Imaging. (a) MRI T2-weighted image of L spine showed L1 compression fracture, degenerative scoliosis without significant spinal stenosis or nerve root compression. (b) MRI T2-weighted image of cervical spine showed no new onset of intraspinal pathology. (c) Brain CT revealed no intracerebral hemorrhage, a... |
PMC9415430_medicina-58-01063-f003_386169.jpg | What is shown in this image? | Postoperative Imaging. (a) MRI T2-weighted image of L spine showed L1 compression fracture, degenerative scoliosis without significant spinal stenosis or nerve root compression. (b) MRI T2-weighted image of cervical spine showed no new onset of intraspinal pathology. (c) Brain CT revealed no intracerebral hemorrhage, a... |
PMC9415461_molecules-27-05261-f001_386182.jpg | What is the main focus of this visual representation? | Snapshot (3D holotomography) of SW1573 cells untreated (control) and treated with PTX, CLC and VBL at 0, 10 and 20 h after exposure. Yellow arrows: subpopulation of cells showing a rounded morphology. Scale bar = 20 µm. |
PMC9415461_molecules-27-05261-f001_386185.jpg | What stands out most in this visual? | Snapshot (3D holotomography) of SW1573 cells untreated (control) and treated with PTX, CLC and VBL at 0, 10 and 20 h after exposure. Yellow arrows: subpopulation of cells showing a rounded morphology. Scale bar = 20 µm. |
PMC9415461_molecules-27-05261-f001_386178.jpg | What is shown in this image? | Snapshot (3D holotomography) of SW1573 cells untreated (control) and treated with PTX, CLC and VBL at 0, 10 and 20 h after exposure. Yellow arrows: subpopulation of cells showing a rounded morphology. Scale bar = 20 µm. |
PMC9415461_molecules-27-05261-f001_386180.jpg | What is the focal point of this photograph? | Snapshot (3D holotomography) of SW1573 cells untreated (control) and treated with PTX, CLC and VBL at 0, 10 and 20 h after exposure. Yellow arrows: subpopulation of cells showing a rounded morphology. Scale bar = 20 µm. |
PMC9415461_molecules-27-05261-f001_386179.jpg | What does this image primarily show? | Snapshot (3D holotomography) of SW1573 cells untreated (control) and treated with PTX, CLC and VBL at 0, 10 and 20 h after exposure. Yellow arrows: subpopulation of cells showing a rounded morphology. Scale bar = 20 µm. |
PMC9415461_molecules-27-05261-f001_386186.jpg | What is the focal point of this photograph? | Snapshot (3D holotomography) of SW1573 cells untreated (control) and treated with PTX, CLC and VBL at 0, 10 and 20 h after exposure. Yellow arrows: subpopulation of cells showing a rounded morphology. Scale bar = 20 µm. |
PMC9415461_molecules-27-05261-f001_386183.jpg | What key item or scene is captured in this photo? | Snapshot (3D holotomography) of SW1573 cells untreated (control) and treated with PTX, CLC and VBL at 0, 10 and 20 h after exposure. Yellow arrows: subpopulation of cells showing a rounded morphology. Scale bar = 20 µm. |
PMC9415461_molecules-27-05261-f002_386190.jpg | What is the principal component of this image? | Snapshot of SW1573 cells treated with microtubule targeting drugs PTX, CLC and VBL. (a) Displaced mitotic spindle from the center of the cell (yellow arrows) during division, with loss of cell polarity; (b) Cells trying to undergo mitosis: Unresolved cytokinesis resulted in a new, polynucleated entity (blue arrow); (c,... |
PMC9415461_molecules-27-05261-f002_386192.jpg | What stands out most in this visual? | Snapshot of SW1573 cells treated with microtubule targeting drugs PTX, CLC and VBL. (a) Displaced mitotic spindle from the center of the cell (yellow arrows) during division, with loss of cell polarity; (b) Cells trying to undergo mitosis: Unresolved cytokinesis resulted in a new, polynucleated entity (blue arrow); (c,... |
PMC9415461_molecules-27-05261-f002_386188.jpg | What is the core subject represented in this visual? | Snapshot of SW1573 cells treated with microtubule targeting drugs PTX, CLC and VBL. (a) Displaced mitotic spindle from the center of the cell (yellow arrows) during division, with loss of cell polarity; (b) Cells trying to undergo mitosis: Unresolved cytokinesis resulted in a new, polynucleated entity (blue arrow); (c,... |
PMC9415461_molecules-27-05261-f002_386196.jpg | What stands out most in this visual? | Snapshot of SW1573 cells treated with microtubule targeting drugs PTX, CLC and VBL. (a) Displaced mitotic spindle from the center of the cell (yellow arrows) during division, with loss of cell polarity; (b) Cells trying to undergo mitosis: Unresolved cytokinesis resulted in a new, polynucleated entity (blue arrow); (c,... |
PMC9415461_molecules-27-05261-f002_386197.jpg | Can you identify the primary element in this image? | Snapshot of SW1573 cells treated with microtubule targeting drugs PTX, CLC and VBL. (a) Displaced mitotic spindle from the center of the cell (yellow arrows) during division, with loss of cell polarity; (b) Cells trying to undergo mitosis: Unresolved cytokinesis resulted in a new, polynucleated entity (blue arrow); (c,... |
PMC9415461_molecules-27-05261-f002_386191.jpg | What's the most prominent thing you notice in this picture? | Snapshot of SW1573 cells treated with microtubule targeting drugs PTX, CLC and VBL. (a) Displaced mitotic spindle from the center of the cell (yellow arrows) during division, with loss of cell polarity; (b) Cells trying to undergo mitosis: Unresolved cytokinesis resulted in a new, polynucleated entity (blue arrow); (c,... |
PMC9415461_molecules-27-05261-f002_386193.jpg | What is shown in this image? | Snapshot of SW1573 cells treated with microtubule targeting drugs PTX, CLC and VBL. (a) Displaced mitotic spindle from the center of the cell (yellow arrows) during division, with loss of cell polarity; (b) Cells trying to undergo mitosis: Unresolved cytokinesis resulted in a new, polynucleated entity (blue arrow); (c,... |
PMC9415461_molecules-27-05261-f002_386195.jpg | What is being portrayed in this visual content? | Snapshot of SW1573 cells treated with microtubule targeting drugs PTX, CLC and VBL. (a) Displaced mitotic spindle from the center of the cell (yellow arrows) during division, with loss of cell polarity; (b) Cells trying to undergo mitosis: Unresolved cytokinesis resulted in a new, polynucleated entity (blue arrow); (c,... |
PMC9415461_molecules-27-05261-f002_386194.jpg | What is shown in this image? | Snapshot of SW1573 cells treated with microtubule targeting drugs PTX, CLC and VBL. (a) Displaced mitotic spindle from the center of the cell (yellow arrows) during division, with loss of cell polarity; (b) Cells trying to undergo mitosis: Unresolved cytokinesis resulted in a new, polynucleated entity (blue arrow); (c,... |
PMC9415461_molecules-27-05261-f002_386189.jpg | What is shown in this image? | Snapshot of SW1573 cells treated with microtubule targeting drugs PTX, CLC and VBL. (a) Displaced mitotic spindle from the center of the cell (yellow arrows) during division, with loss of cell polarity; (b) Cells trying to undergo mitosis: Unresolved cytokinesis resulted in a new, polynucleated entity (blue arrow); (c,... |
PMC9415470_pathogens-11-00926-f001_386202.jpg | Describe the main subject of this image. | E. coli (A–C), E. faecalis (D–F), and GBS (G–I) invasion of an exfoliated urothelial cell from women with refractory DO. Cells were fluorescently stained and subsequently imaged using confocal microscopy. (A,D,G) Orthogonal views were obtained to visualise the location of all structures relative to the urothelial cell ... |
PMC9415470_pathogens-11-00926-f001_386204.jpg | What is the focal point of this photograph? | E. coli (A–C), E. faecalis (D–F), and GBS (G–I) invasion of an exfoliated urothelial cell from women with refractory DO. Cells were fluorescently stained and subsequently imaged using confocal microscopy. (A,D,G) Orthogonal views were obtained to visualise the location of all structures relative to the urothelial cell ... |
PMC9415470_pathogens-11-00926-f001_386203.jpg | What is the principal component of this image? | E. coli (A–C), E. faecalis (D–F), and GBS (G–I) invasion of an exfoliated urothelial cell from women with refractory DO. Cells were fluorescently stained and subsequently imaged using confocal microscopy. (A,D,G) Orthogonal views were obtained to visualise the location of all structures relative to the urothelial cell ... |
PMC9415470_pathogens-11-00926-f001_386199.jpg | Can you identify the primary element in this image? | E. coli (A–C), E. faecalis (D–F), and GBS (G–I) invasion of an exfoliated urothelial cell from women with refractory DO. Cells were fluorescently stained and subsequently imaged using confocal microscopy. (A,D,G) Orthogonal views were obtained to visualise the location of all structures relative to the urothelial cell ... |
PMC9415470_pathogens-11-00926-f001_386200.jpg | What can you see in this picture? | E. coli (A–C), E. faecalis (D–F), and GBS (G–I) invasion of an exfoliated urothelial cell from women with refractory DO. Cells were fluorescently stained and subsequently imaged using confocal microscopy. (A,D,G) Orthogonal views were obtained to visualise the location of all structures relative to the urothelial cell ... |
PMC9415495_tomography-08-00170-f002_386207.jpg | What key item or scene is captured in this photo? | Example of sequences with good agreement for tumor volume delineation in high-grade glioma between readers: (A) CE T1-weighted imaging (T1-GD) (B) T2-weighted fluid-attenuated inversion recovery (T2-FLAIR), which appears in hypersignal. (C) 18F-FET PET/CT. |
PMC9415495_tomography-08-00170-f002_386208.jpg | What is the dominant medical problem in this image? | Example of sequences with good agreement for tumor volume delineation in high-grade glioma between readers: (A) CE T1-weighted imaging (T1-GD) (B) T2-weighted fluid-attenuated inversion recovery (T2-FLAIR), which appears in hypersignal. (C) 18F-FET PET/CT. |
PMC9415495_tomography-08-00170-f002_386209.jpg | Can you identify the primary element in this image? | Example of sequences with good agreement for tumor volume delineation in high-grade glioma between readers: (A) CE T1-weighted imaging (T1-GD) (B) T2-weighted fluid-attenuated inversion recovery (T2-FLAIR), which appears in hypersignal. (C) 18F-FET PET/CT. |
PMC9415495_tomography-08-00170-f003_386211.jpg | What does this image primarily show? | Example of sequences with poor agreement for tumor volume delineation in high-grade glioma between readers: (A) Relative cerebral blood volume (rCVB) corrected for contrast leakage shows. (B) Permeability estimation map (k2). (C) Diffusion-weighted imaging (DWI b1000). (D) Apparent diffusion coefficient (ADC) map. In t... |
PMC9415495_tomography-08-00170-f003_386210.jpg | What is the principal component of this image? | Example of sequences with poor agreement for tumor volume delineation in high-grade glioma between readers: (A) Relative cerebral blood volume (rCVB) corrected for contrast leakage shows. (B) Permeability estimation map (k2). (C) Diffusion-weighted imaging (DWI b1000). (D) Apparent diffusion coefficient (ADC) map. In t... |
PMC9415510_vaccines-10-01286-f001_386217.jpg | What is shown in this image? | Acute polyserositis with cardiac tamponade and bilateral refractory pleural effusion after ChAdOx1 nCoV-19 vaccination. (A) Chest X-ray shows the typical water bottle sign, which refers to the shape of the cardiac silhouette in patients who have a large pericardial effusion. The fluid causes the pericardium to sag, mim... |
PMC9415510_vaccines-10-01286-f001_386218.jpg | What can you see in this picture? | Acute polyserositis with cardiac tamponade and bilateral refractory pleural effusion after ChAdOx1 nCoV-19 vaccination. (A) Chest X-ray shows the typical water bottle sign, which refers to the shape of the cardiac silhouette in patients who have a large pericardial effusion. The fluid causes the pericardium to sag, mim... |
PMC9415510_vaccines-10-01286-f002_386214.jpg | What stands out most in this visual? | Transthoracic echocardiography captured on the 45th day during hospitalization. The subcostal view shows a small amount of pericardial effusion and massive refractory pleural effusion bilaterally. LPE = left pleural effusion; RPE = right pleural effusion. |
PMC9415510_vaccines-10-01286-f004_386215.jpg | Describe the main subject of this image. | Repeated image studies during follow-up at the outpatient clinic. Chest X-ray (A) and the subcostal view of transthoracic echocardiography (B). Both show no recurrence of the effusion. |
PMC9415510_vaccines-10-01286-f004_386216.jpg | What does this image primarily show? | Repeated image studies during follow-up at the outpatient clinic. Chest X-ray (A) and the subcostal view of transthoracic echocardiography (B). Both show no recurrence of the effusion. |
PMC9415513_tomography-08-00168-f001_386220.jpg | What is the central feature of this picture? | Example of a positive mpMRI prostate nodule, showing the original software interface with the segmentation of the lesion (a) and post-contrast enhancement curve (b). |
PMC9415513_tomography-08-00168-f001_386222.jpg | What is the principal component of this image? | Example of a positive mpMRI prostate nodule, showing the original software interface with the segmentation of the lesion (a) and post-contrast enhancement curve (b). |
PMC9415513_tomography-08-00168-f001_386221.jpg | What's the most prominent thing you notice in this picture? | Example of a positive mpMRI prostate nodule, showing the original software interface with the segmentation of the lesion (a) and post-contrast enhancement curve (b). |
PMC9415524_fig-1_386239.jpg | What is the central feature of this picture? | Identification of ploidy level and genome composition of gonocytes, spermatocytes, and spermatids from P. esculentus males collected from the Mozh river basin.FISH with RrS1 probe helps distinguish pericentromeric regions only of P. ridibundus chromosomes (indicated by thin arrows). (A–C) Somatic cells (C), spermatids ... |
PMC9415524_fig-1_386234.jpg | What is the central feature of this picture? | Identification of ploidy level and genome composition of gonocytes, spermatocytes, and spermatids from P. esculentus males collected from the Mozh river basin.FISH with RrS1 probe helps distinguish pericentromeric regions only of P. ridibundus chromosomes (indicated by thin arrows). (A–C) Somatic cells (C), spermatids ... |
PMC9415524_fig-1_386235.jpg | What object or scene is depicted here? | Identification of ploidy level and genome composition of gonocytes, spermatocytes, and spermatids from P. esculentus males collected from the Mozh river basin.FISH with RrS1 probe helps distinguish pericentromeric regions only of P. ridibundus chromosomes (indicated by thin arrows). (A–C) Somatic cells (C), spermatids ... |
PMC9415524_fig-1_386232.jpg | What is being portrayed in this visual content? | Identification of ploidy level and genome composition of gonocytes, spermatocytes, and spermatids from P. esculentus males collected from the Mozh river basin.FISH with RrS1 probe helps distinguish pericentromeric regions only of P. ridibundus chromosomes (indicated by thin arrows). (A–C) Somatic cells (C), spermatids ... |
PMC9415524_fig-1_386238.jpg | What is being portrayed in this visual content? | Identification of ploidy level and genome composition of gonocytes, spermatocytes, and spermatids from P. esculentus males collected from the Mozh river basin.FISH with RrS1 probe helps distinguish pericentromeric regions only of P. ridibundus chromosomes (indicated by thin arrows). (A–C) Somatic cells (C), spermatids ... |
PMC9415524_fig-1_386233.jpg | Can you identify the primary element in this image? | Identification of ploidy level and genome composition of gonocytes, spermatocytes, and spermatids from P. esculentus males collected from the Mozh river basin.FISH with RrS1 probe helps distinguish pericentromeric regions only of P. ridibundus chromosomes (indicated by thin arrows). (A–C) Somatic cells (C), spermatids ... |
PMC9415524_fig-1_386237.jpg | What is the focal point of this photograph? | Identification of ploidy level and genome composition of gonocytes, spermatocytes, and spermatids from P. esculentus males collected from the Mozh river basin.FISH with RrS1 probe helps distinguish pericentromeric regions only of P. ridibundus chromosomes (indicated by thin arrows). (A–C) Somatic cells (C), spermatids ... |
PMC9415524_fig-2_386225.jpg | What does this image primarily show? | Identification of ploidy level and genome composition of gonocytes, spermatocytes and spermatids from particular P. esculentus male producing diploid spermatids collected from the Mozh river basin.Interphase cell nuclei (indicated by thick arrows) with diploid P. ridibundus chromosomal set (A, D). Mitotic metaphases wi... |
PMC9415524_fig-2_386226.jpg | What is the principal component of this image? | Identification of ploidy level and genome composition of gonocytes, spermatocytes and spermatids from particular P. esculentus male producing diploid spermatids collected from the Mozh river basin.Interphase cell nuclei (indicated by thick arrows) with diploid P. ridibundus chromosomal set (A, D). Mitotic metaphases wi... |
PMC9415524_fig-2_386231.jpg | What is the dominant medical problem in this image? | Identification of ploidy level and genome composition of gonocytes, spermatocytes and spermatids from particular P. esculentus male producing diploid spermatids collected from the Mozh river basin.Interphase cell nuclei (indicated by thick arrows) with diploid P. ridibundus chromosomal set (A, D). Mitotic metaphases wi... |
PMC9415524_fig-2_386230.jpg | What is the central feature of this picture? | Identification of ploidy level and genome composition of gonocytes, spermatocytes and spermatids from particular P. esculentus male producing diploid spermatids collected from the Mozh river basin.Interphase cell nuclei (indicated by thick arrows) with diploid P. ridibundus chromosomal set (A, D). Mitotic metaphases wi... |
PMC9415567_tropicalmed-07-00169-f003_386242.jpg | Can you identify the primary element in this image? | Ultrasonographic images of an MGS positive study participant with abnormalities in the bladder and prostate at Baseline. (A,B). Irregular urinary bladder wall and severe focal thickness, measuring up to 13.6 mm. (C). Normal symmetrical seminal vesicles. (D). Prostate with abnormal irregular outline, but normal volume o... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.